Approvals/CIMA-AEMPS/COMIRNATY KP.2 3 MICROGRAMOS/DOSIS CONCENTRADO PARA DISPERSION INYECTABLE

Approved

STANDARD

COMIRNATY KP.2 3 MICROGRAMOS/DOSIS CONCENTRADO PARA DISPERSION INYECTABLE

Biontech Manufacturing Gmbh🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 28c3919446df21f0
Drug Cima Aemps Name: COMIRNATY KP.2 3 MICROGRAMOS/DOSIS CONCENTRADO PARA DISPERSION INYECTABLE
Register Number: 1201528042
Holder Company Name: Biontech Manufacturing Gmbh
Marketing Company Name: Pfizer S.L.
Holder Company Detail Path: /organization/biontech-manufacturing-gmbh
Authorization Date: 2024-10-03
Dosage Form: CONCENTRADO PARA DISPERSION INYECTABLE
Dose: 3 microgramos
Route Of Administration: VÍA INTRAMUSCULAR
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Biontech Manufacturing Gmbh
Company Detail Path: /organization/biontech-manufacturing-gmbh

VACUNA DE ARNM QUE CODIFICA LA PROTEINA DE LA ESPICULA (S) VIRAL DEL SARS-COV-2 (OMICRON KP.2)

3 µg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Oct 3, 2024

Approval ID

28c3919446df21f0

Type

Standard